Terms: = Sarcomas AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Prognosis
4 results:
1. c-myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1.
Luo P; Fang J; Chen H; He F; Xiao S; Liu H; Zhu S; Luo J; Jiang C
Sci Rep; 2022 Apr; 12(1):6692. PubMed ID: 35461324
[TBL] [Abstract] [Full Text] [Related]
2. Transcription factor c-myb: novel prognostic factor in osteosarcoma.
Říhová K; Dúcka M; Zambo IS; Vymětalová L; Šrámek M; Trčka F; Verner J; Drápela S; Fedr R; Suchánková T; Pavlatovská B; Ondroušková E; Kubelková I; Zapletalová D; Tuček Š; Múdry P; Krákorová DA; Knopfová L; Šmarda J; Souček K; Borsig L; Beneš P
Clin Exp Metastasis; 2022 Apr; 39(2):375-390. PubMed ID: 34994868
[TBL] [Abstract] [Full Text] [Related]
3. The Expression of c-myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin.
Kaspar P; Zikova M; Bartunek P; Sterba J; Strnad H; Kren L; Sedlacek R
Sci Rep; 2015 Oct; 5():15090. PubMed ID: 26462877
[TBL] [Abstract] [Full Text] [Related]
4. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract] [Full Text] [Related]
